Request for Covid-19 Impact Assessment of this Report
The United States Swine Influenza Vaccines market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Swine Influenza Vaccines market, reaching US$ million by the year 2028. As for the Europe Swine Influenza Vaccines landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Swine Influenza Vaccines players cover Chengdu TECBOND, Green Cross Veterinary, Hipra, and MSD Animal Health (Merck), etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Swine Influenza Vaccines market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Live Vaccines
Killed Vaccines
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Commodity Pig
Breeding Pig
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Chengdu TECBOND
Green Cross Veterinary
Hipra
MSD Animal Health (Merck)
Zoetis
CAHIC
Merial
Ceva
Ringpu Biology
DHN
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Swine Influenza Vaccines Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Swine Influenza Vaccines by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Swine Influenza Vaccines by Country/Region, 2017, 2022 & 2028
2.2 Swine Influenza Vaccines Segment by Type
2.2.1 Live Vaccines
2.2.2 Killed Vaccines
2.3 Swine Influenza Vaccines Sales by Type
2.3.1 Global Swine Influenza Vaccines Sales Market Share by Type (2017-2022)
2.3.2 Global Swine Influenza Vaccines Revenue and Market Share by Type (2017-2022)
2.3.3 Global Swine Influenza Vaccines Sale Price by Type (2017-2022)
2.4 Swine Influenza Vaccines Segment by Application
2.4.1 Commodity Pig
2.4.2 Breeding Pig
2.5 Swine Influenza Vaccines Sales by Application
2.5.1 Global Swine Influenza Vaccines Sale Market Share by Application (2017-2022)
2.5.2 Global Swine Influenza Vaccines Revenue and Market Share by Application (2017-2022)
2.5.3 Global Swine Influenza Vaccines Sale Price by Application (2017-2022)
3 Global Swine Influenza Vaccines by Company
3.1 Global Swine Influenza Vaccines Breakdown Data by Company
3.1.1 Global Swine Influenza Vaccines Annual Sales by Company (2020-2022)
3.1.2 Global Swine Influenza Vaccines Sales Market Share by Company (2020-2022)
3.2 Global Swine Influenza Vaccines Annual Revenue by Company (2020-2022)
3.2.1 Global Swine Influenza Vaccines Revenue by Company (2020-2022)
3.2.2 Global Swine Influenza Vaccines Revenue Market Share by Company (2020-2022)
3.3 Global Swine Influenza Vaccines Sale Price by Company
3.4 Key Manufacturers Swine Influenza Vaccines Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Swine Influenza Vaccines Product Location Distribution
3.4.2 Players Swine Influenza Vaccines Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Swine Influenza Vaccines by Geographic Region
4.1 World Historic Swine Influenza Vaccines Market Size by Geographic Region (2017-2022)
4.1.1 Global Swine Influenza Vaccines Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Swine Influenza Vaccines Annual Revenue by Geographic Region
4.2 World Historic Swine Influenza Vaccines Market Size by Country/Region (2017-2022)
4.2.1 Global Swine Influenza Vaccines Annual Sales by Country/Region (2017-2022)
4.2.2 Global Swine Influenza Vaccines Annual Revenue by Country/Region
4.3 Americas Swine Influenza Vaccines Sales Growth
4.4 APAC Swine Influenza Vaccines Sales Growth
4.5 Europe Swine Influenza Vaccines Sales Growth
4.6 Middle East & Africa Swine Influenza Vaccines Sales Growth
5 Americas
5.1 Americas Swine Influenza Vaccines Sales by Country
5.1.1 Americas Swine Influenza Vaccines Sales by Country (2017-2022)
5.1.2 Americas Swine Influenza Vaccines Revenue by Country (2017-2022)
5.2 Americas Swine Influenza Vaccines Sales by Type
5.3 Americas Swine Influenza Vaccines Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Swine Influenza Vaccines Sales by Region
6.1.1 APAC Swine Influenza Vaccines Sales by Region (2017-2022)
6.1.2 APAC Swine Influenza Vaccines Revenue by Region (2017-2022)
6.2 APAC Swine Influenza Vaccines Sales by Type
6.3 APAC Swine Influenza Vaccines Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Swine Influenza Vaccines by Country
7.1.1 Europe Swine Influenza Vaccines Sales by Country (2017-2022)
7.1.2 Europe Swine Influenza Vaccines Revenue by Country (2017-2022)
7.2 Europe Swine Influenza Vaccines Sales by Type
7.3 Europe Swine Influenza Vaccines Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Swine Influenza Vaccines by Country
8.1.1 Middle East & Africa Swine Influenza Vaccines Sales by Country (2017-2022)
8.1.2 Middle East & Africa Swine Influenza Vaccines Revenue by Country (2017-2022)
8.2 Middle East & Africa Swine Influenza Vaccines Sales by Type
8.3 Middle East & Africa Swine Influenza Vaccines Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Swine Influenza Vaccines
10.3 Manufacturing Process Analysis of Swine Influenza Vaccines
10.4 Industry Chain Structure of Swine Influenza Vaccines
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Swine Influenza Vaccines Distributors
11.3 Swine Influenza Vaccines Customer
12 World Forecast Review for Swine Influenza Vaccines by Geographic Region
12.1 Global Swine Influenza Vaccines Market Size Forecast by Region
12.1.1 Global Swine Influenza Vaccines Forecast by Region (2023-2028)
12.1.2 Global Swine Influenza Vaccines Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Swine Influenza Vaccines Forecast by Type
12.7 Global Swine Influenza Vaccines Forecast by Application
13 Key Players Analysis
13.1 Chengdu TECBOND
13.1.1 Chengdu TECBOND Company Information
13.1.2 Chengdu TECBOND Swine Influenza Vaccines Product Offered
13.1.3 Chengdu TECBOND Swine Influenza Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Chengdu TECBOND Main Business Overview
13.1.5 Chengdu TECBOND Latest Developments
13.2 Green Cross Veterinary
13.2.1 Green Cross Veterinary Company Information
13.2.2 Green Cross Veterinary Swine Influenza Vaccines Product Offered
13.2.3 Green Cross Veterinary Swine Influenza Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Green Cross Veterinary Main Business Overview
13.2.5 Green Cross Veterinary Latest Developments
13.3 Hipra
13.3.1 Hipra Company Information
13.3.2 Hipra Swine Influenza Vaccines Product Offered
13.3.3 Hipra Swine Influenza Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Hipra Main Business Overview
13.3.5 Hipra Latest Developments
13.4 MSD Animal Health (Merck)
13.4.1 MSD Animal Health (Merck) Company Information
13.4.2 MSD Animal Health (Merck) Swine Influenza Vaccines Product Offered
13.4.3 MSD Animal Health (Merck) Swine Influenza Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 MSD Animal Health (Merck) Main Business Overview
13.4.5 MSD Animal Health (Merck) Latest Developments
13.5 Zoetis
13.5.1 Zoetis Company Information
13.5.2 Zoetis Swine Influenza Vaccines Product Offered
13.5.3 Zoetis Swine Influenza Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Zoetis Main Business Overview
13.5.5 Zoetis Latest Developments
13.6 CAHIC
13.6.1 CAHIC Company Information
13.6.2 CAHIC Swine Influenza Vaccines Product Offered
13.6.3 CAHIC Swine Influenza Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 CAHIC Main Business Overview
13.6.5 CAHIC Latest Developments
13.7 Merial
13.7.1 Merial Company Information
13.7.2 Merial Swine Influenza Vaccines Product Offered
13.7.3 Merial Swine Influenza Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Merial Main Business Overview
13.7.5 Merial Latest Developments
13.8 Ceva
13.8.1 Ceva Company Information
13.8.2 Ceva Swine Influenza Vaccines Product Offered
13.8.3 Ceva Swine Influenza Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Ceva Main Business Overview
13.8.5 Ceva Latest Developments
13.9 Ringpu Biology
13.9.1 Ringpu Biology Company Information
13.9.2 Ringpu Biology Swine Influenza Vaccines Product Offered
13.9.3 Ringpu Biology Swine Influenza Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Ringpu Biology Main Business Overview
13.9.5 Ringpu Biology Latest Developments
13.10 DHN
13.10.1 DHN Company Information
13.10.2 DHN Swine Influenza Vaccines Product Offered
13.10.3 DHN Swine Influenza Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 DHN Main Business Overview
13.10.5 DHN Latest Developments
14 Research Findings and Conclusion
Table 1. Swine Influenza Vaccines Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Swine Influenza Vaccines Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Live Vaccines
Table 4. Major Players of Killed Vaccines
Table 5. Global Swine Influenza Vaccines Sales by Type (2017-2022) & (K Units)
Table 6. Global Swine Influenza Vaccines Sales Market Share by Type (2017-2022)
Table 7. Global Swine Influenza Vaccines Revenue by Type (2017-2022) & ($ million)
Table 8. Global Swine Influenza Vaccines Revenue Market Share by Type (2017-2022)
Table 9. Global Swine Influenza Vaccines Sale Price by Type (2017-2022) & (USD/Unit)
Table 10. Global Swine Influenza Vaccines Sales by Application (2017-2022) & (K Units)
Table 11. Global Swine Influenza Vaccines Sales Market Share by Application (2017-2022)
Table 12. Global Swine Influenza Vaccines Revenue by Application (2017-2022)
Table 13. Global Swine Influenza Vaccines Revenue Market Share by Application (2017-2022)
Table 14. Global Swine Influenza Vaccines Sale Price by Application (2017-2022) & (USD/Unit)
Table 15. Global Swine Influenza Vaccines Sales by Company (2020-2022) & (K Units)
Table 16. Global Swine Influenza Vaccines Sales Market Share by Company (2020-2022)
Table 17. Global Swine Influenza Vaccines Revenue by Company (2020-2022) ($ Millions)
Table 18. Global Swine Influenza Vaccines Revenue Market Share by Company (2020-2022)
Table 19. Global Swine Influenza Vaccines Sale Price by Company (2020-2022) & (USD/Unit)
Table 20. Key Manufacturers Swine Influenza Vaccines Producing Area Distribution and Sales Area
Table 21. Players Swine Influenza Vaccines Products Offered
Table 22. Swine Influenza Vaccines Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Swine Influenza Vaccines Sales by Geographic Region (2017-2022) & (K Units)
Table 26. Global Swine Influenza Vaccines Sales Market Share Geographic Region (2017-2022)
Table 27. Global Swine Influenza Vaccines Revenue by Geographic Region (2017-2022) & ($ millions)
Table 28. Global Swine Influenza Vaccines Revenue Market Share by Geographic Region (2017-2022)
Table 29. Global Swine Influenza Vaccines Sales by Country/Region (2017-2022) & (K Units)
Table 30. Global Swine Influenza Vaccines Sales Market Share by Country/Region (2017-2022)
Table 31. Global Swine Influenza Vaccines Revenue by Country/Region (2017-2022) & ($ millions)
Table 32. Global Swine Influenza Vaccines Revenue Market Share by Country/Region (2017-2022)
Table 33. Americas Swine Influenza Vaccines Sales by Country (2017-2022) & (K Units)
Table 34. Americas Swine Influenza Vaccines Sales Market Share by Country (2017-2022)
Table 35. Americas Swine Influenza Vaccines Revenue by Country (2017-2022) & ($ Millions)
Table 36. Americas Swine Influenza Vaccines Revenue Market Share by Country (2017-2022)
Table 37. Americas Swine Influenza Vaccines Sales by Type (2017-2022) & (K Units)
Table 38. Americas Swine Influenza Vaccines Sales Market Share by Type (2017-2022)
Table 39. Americas Swine Influenza Vaccines Sales by Application (2017-2022) & (K Units)
Table 40. Americas Swine Influenza Vaccines Sales Market Share by Application (2017-2022)
Table 41. APAC Swine Influenza Vaccines Sales by Region (2017-2022) & (K Units)
Table 42. APAC Swine Influenza Vaccines Sales Market Share by Region (2017-2022)
Table 43. APAC Swine Influenza Vaccines Revenue by Region (2017-2022) & ($ Millions)
Table 44. APAC Swine Influenza Vaccines Revenue Market Share by Region (2017-2022)
Table 45. APAC Swine Influenza Vaccines Sales by Type (2017-2022) & (K Units)
Table 46. APAC Swine Influenza Vaccines Sales Market Share by Type (2017-2022)
Table 47. APAC Swine Influenza Vaccines Sales by Application (2017-2022) & (K Units)
Table 48. APAC Swine Influenza Vaccines Sales Market Share by Application (2017-2022)
Table 49. Europe Swine Influenza Vaccines Sales by Country (2017-2022) & (K Units)
Table 50. Europe Swine Influenza Vaccines Sales Market Share by Country (2017-2022)
Table 51. Europe Swine Influenza Vaccines Revenue by Country (2017-2022) & ($ Millions)
Table 52. Europe Swine Influenza Vaccines Revenue Market Share by Country (2017-2022)
Table 53. Europe Swine Influenza Vaccines Sales by Type (2017-2022) & (K Units)
Table 54. Europe Swine Influenza Vaccines Sales Market Share by Type (2017-2022)
Table 55. Europe Swine Influenza Vaccines Sales by Application (2017-2022) & (K Units)
Table 56. Europe Swine Influenza Vaccines Sales Market Share by Application (2017-2022)
Table 57. Middle East & Africa Swine Influenza Vaccines Sales by Country (2017-2022) & (K Units)
Table 58. Middle East & Africa Swine Influenza Vaccines Sales Market Share by Country (2017-2022)
Table 59. Middle East & Africa Swine Influenza Vaccines Revenue by Country (2017-2022) & ($ Millions)
Table 60. Middle East & Africa Swine Influenza Vaccines Revenue Market Share by Country (2017-2022)
Table 61. Middle East & Africa Swine Influenza Vaccines Sales by Type (2017-2022) & (K Units)
Table 62. Middle East & Africa Swine Influenza Vaccines Sales Market Share by Type (2017-2022)
Table 63. Middle East & Africa Swine Influenza Vaccines Sales by Application (2017-2022) & (K Units)
Table 64. Middle East & Africa Swine Influenza Vaccines Sales Market Share by Application (2017-2022)
Table 65. Key Market Drivers & Growth Opportunities of Swine Influenza Vaccines
Table 66. Key Market Challenges & Risks of Swine Influenza Vaccines
Table 67. Key Industry Trends of Swine Influenza Vaccines
Table 68. Swine Influenza Vaccines Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. Swine Influenza Vaccines Distributors List
Table 71. Swine Influenza Vaccines Customer List
Table 72. Global Swine Influenza Vaccines Sales Forecast by Region (2023-2028) & (K Units)
Table 73. Global Swine Influenza Vaccines Sales Market Forecast by Region
Table 74. Global Swine Influenza Vaccines Revenue Forecast by Region (2023-2028) & ($ millions)
Table 75. Global Swine Influenza Vaccines Revenue Market Share Forecast by Region (2023-2028)
Table 76. Americas Swine Influenza Vaccines Sales Forecast by Country (2023-2028) & (K Units)
Table 77. Americas Swine Influenza Vaccines Revenue Forecast by Country (2023-2028) & ($ millions)
Table 78. APAC Swine Influenza Vaccines Sales Forecast by Region (2023-2028) & (K Units)
Table 79. APAC Swine Influenza Vaccines Revenue Forecast by Region (2023-2028) & ($ millions)
Table 80. Europe Swine Influenza Vaccines Sales Forecast by Country (2023-2028) & (K Units)
Table 81. Europe Swine Influenza Vaccines Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. Middle East & Africa Swine Influenza Vaccines Sales Forecast by Country (2023-2028) & (K Units)
Table 83. Middle East & Africa Swine Influenza Vaccines Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Global Swine Influenza Vaccines Sales Forecast by Type (2023-2028) & (K Units)
Table 85. Global Swine Influenza Vaccines Sales Market Share Forecast by Type (2023-2028)
Table 86. Global Swine Influenza Vaccines Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 87. Global Swine Influenza Vaccines Revenue Market Share Forecast by Type (2023-2028)
Table 88. Global Swine Influenza Vaccines Sales Forecast by Application (2023-2028) & (K Units)
Table 89. Global Swine Influenza Vaccines Sales Market Share Forecast by Application (2023-2028)
Table 90. Global Swine Influenza Vaccines Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 91. Global Swine Influenza Vaccines Revenue Market Share Forecast by Application (2023-2028)
Table 92. Chengdu TECBOND Basic Information, Swine Influenza Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 93. Chengdu TECBOND Swine Influenza Vaccines Product Offered
Table 94. Chengdu TECBOND Swine Influenza Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 95. Chengdu TECBOND Main Business
Table 96. Chengdu TECBOND Latest Developments
Table 97. Green Cross Veterinary Basic Information, Swine Influenza Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 98. Green Cross Veterinary Swine Influenza Vaccines Product Offered
Table 99. Green Cross Veterinary Swine Influenza Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 100. Green Cross Veterinary Main Business
Table 101. Green Cross Veterinary Latest Developments
Table 102. Hipra Basic Information, Swine Influenza Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 103. Hipra Swine Influenza Vaccines Product Offered
Table 104. Hipra Swine Influenza Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 105. Hipra Main Business
Table 106. Hipra Latest Developments
Table 107. MSD Animal Health (Merck) Basic Information, Swine Influenza Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 108. MSD Animal Health (Merck) Swine Influenza Vaccines Product Offered
Table 109. MSD Animal Health (Merck) Swine Influenza Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 110. MSD Animal Health (Merck) Main Business
Table 111. MSD Animal Health (Merck) Latest Developments
Table 112. Zoetis Basic Information, Swine Influenza Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 113. Zoetis Swine Influenza Vaccines Product Offered
Table 114. Zoetis Swine Influenza Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 115. Zoetis Main Business
Table 116. Zoetis Latest Developments
Table 117. CAHIC Basic Information, Swine Influenza Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 118. CAHIC Swine Influenza Vaccines Product Offered
Table 119. CAHIC Swine Influenza Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 120. CAHIC Main Business
Table 121. CAHIC Latest Developments
Table 122. Merial Basic Information, Swine Influenza Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 123. Merial Swine Influenza Vaccines Product Offered
Table 124. Merial Swine Influenza Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 125. Merial Main Business
Table 126. Merial Latest Developments
Table 127. Ceva Basic Information, Swine Influenza Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 128. Ceva Swine Influenza Vaccines Product Offered
Table 129. Ceva Swine Influenza Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 130. Ceva Main Business
Table 131. Ceva Latest Developments
Table 132. Ringpu Biology Basic Information, Swine Influenza Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 133. Ringpu Biology Swine Influenza Vaccines Product Offered
Table 134. Ringpu Biology Swine Influenza Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 135. Ringpu Biology Main Business
Table 136. Ringpu Biology Latest Developments
Table 137. DHN Basic Information, Swine Influenza Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 138. DHN Swine Influenza Vaccines Product Offered
Table 139. DHN Swine Influenza Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 140. DHN Main Business
Table 141. DHN Latest Developments
List of Figures
Figure 1. Picture of Swine Influenza Vaccines
Figure 2. Swine Influenza Vaccines Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Swine Influenza Vaccines Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Swine Influenza Vaccines Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Swine Influenza Vaccines Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Live Vaccines
Figure 10. Product Picture of Killed Vaccines
Figure 11. Global Swine Influenza Vaccines Sales Market Share by Type in 2021
Figure 12. Global Swine Influenza Vaccines Revenue Market Share by Type (2017-2022)
Figure 13. Swine Influenza Vaccines Consumed in Commodity Pig
Figure 14. Global Swine Influenza Vaccines Market: Commodity Pig (2017-2022) & (K Units)
Figure 15. Swine Influenza Vaccines Consumed in Breeding Pig
Figure 16. Global Swine Influenza Vaccines Market: Breeding Pig (2017-2022) & (K Units)
Figure 17. Global Swine Influenza Vaccines Sales Market Share by Application (2017-2022)
Figure 18. Global Swine Influenza Vaccines Revenue Market Share by Application in 2021
Figure 19. Swine Influenza Vaccines Revenue Market by Company in 2021 ($ Million)
Figure 20. Global Swine Influenza Vaccines Revenue Market Share by Company in 2021
Figure 21. Global Swine Influenza Vaccines Sales Market Share by Geographic Region (2017-2022)
Figure 22. Global Swine Influenza Vaccines Revenue Market Share by Geographic Region in 2021
Figure 23. Global Swine Influenza Vaccines Sales Market Share by Region (2017-2022)
Figure 24. Global Swine Influenza Vaccines Revenue Market Share by Country/Region in 2021
Figure 25. Americas Swine Influenza Vaccines Sales 2017-2022 (K Units)
Figure 26. Americas Swine Influenza Vaccines Revenue 2017-2022 ($ Millions)
Figure 27. APAC Swine Influenza Vaccines Sales 2017-2022 (K Units)
Figure 28. APAC Swine Influenza Vaccines Revenue 2017-2022 ($ Millions)
Figure 29. Europe Swine Influenza Vaccines Sales 2017-2022 (K Units)
Figure 30. Europe Swine Influenza Vaccines Revenue 2017-2022 ($ Millions)
Figure 31. Middle East & Africa Swine Influenza Vaccines Sales 2017-2022 (K Units)
Figure 32. Middle East & Africa Swine Influenza Vaccines Revenue 2017-2022 ($ Millions)
Figure 33. Americas Swine Influenza Vaccines Sales Market Share by Country in 2021
Figure 34. Americas Swine Influenza Vaccines Revenue Market Share by Country in 2021
Figure 35. United States Swine Influenza Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 36. Canada Swine Influenza Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 37. Mexico Swine Influenza Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 38. Brazil Swine Influenza Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 39. APAC Swine Influenza Vaccines Sales Market Share by Region in 2021
Figure 40. APAC Swine Influenza Vaccines Revenue Market Share by Regions in 2021
Figure 41. China Swine Influenza Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 42. Japan Swine Influenza Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 43. South Korea Swine Influenza Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 44. Southeast Asia Swine Influenza Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 45. India Swine Influenza Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 46. Australia Swine Influenza Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 47. Europe Swine Influenza Vaccines Sales Market Share by Country in 2021
Figure 48. Europe Swine Influenza Vaccines Revenue Market Share by Country in 2021
Figure 49. Germany Swine Influenza Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 50. France Swine Influenza Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 51. UK Swine Influenza Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 52. Italy Swine Influenza Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 53. Russia Swine Influenza Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 54. Middle East & Africa Swine Influenza Vaccines Sales Market Share by Country in 2021
Figure 55. Middle East & Africa Swine Influenza Vaccines Revenue Market Share by Country in 2021
Figure 56. Egypt Swine Influenza Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 57. South Africa Swine Influenza Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 58. Israel Swine Influenza Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 59. Turkey Swine Influenza Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 60. GCC Country Swine Influenza Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 61. Manufacturing Cost Structure Analysis of Swine Influenza Vaccines in 2021
Figure 62. Manufacturing Process Analysis of Swine Influenza Vaccines
Figure 63. Industry Chain Structure of Swine Influenza Vaccines
Figure 64. Channels of Distribution
Figure 65. Distributors Profiles
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...